Access the full text.
Sign up today, get DeepDyve free for 14 days.
Michelle Furler, T. Einarson, M. Millson, S. Walmsley, R. Bendayan (2004)
Medicinal and recreational marijuana use by patients infected with HIV.AIDS patient care and STDs, 18 4
J. Kirk, H. Wit (1999)
Responses to Oral Δ9-Tetrahydrocannabinol in Frequent and Infrequent Marijuana UsersPharmacology Biochemistry and Behavior, 63
DI Abrams (1998)
Medical marijuana: trials and tribulationsJ Psychoactive Drugs, 30
(2003)
Interaction between naltrexone
Emily Woolridge, S. Barton, J. Samuel, J. Osório, A. Dougherty, A. Holdcroft (2005)
Cannabis use in HIV for pain and other medical symptoms.Journal of pain and symptom management, 29 4
C. Sachse-Seeboth, J. Pfeil, D. Sehrt, I. Meineke, M. Tzvetkov, E. Bruns, W. Poser, SV Vormfelde, J. Brockmöller (2009)
Interindividual Variation in the Pharmacokinetics of Δ9‐Tetrahydrocannabinol as Related to Genetic Polymorphisms in CYP2C9Clinical Pharmacology & Therapeutics, 85
Melissa Struwe, S. Kaempfer, C. Geiger, A. Pavia, T. Plasse, K. Shepard, K. Ries, T. Evans (1993)
Effect of Dronabinol on Nutritional Status in HIV InfectionAnnals of Pharmacotherapy, 27
M. Folstein, Richard Luria (1973)
Reliability, validity, and clinical application of the visual analogue mood scalePsychological Medicine, 3
(2003)
Medical marijuana initiatives . Are they justified ? How successful are they likely to be ?
M. Haney, A. Ward, S. Comer, R. Foltin, M. Fischman (1999)
Abstinence symptoms following oral THC administration to humansPsychopharmacology, 141
(1997)
Long - term efficacy and safety of dronabinol for acquired immunodeficiency syndromeassociated anorexia
M. Ware, S. Rueda, J. Singer, D. Kilby (2003)
Cannabis Use by Persons Living with HIV/AIDS: Patterns and Prevalence of Use, 3
J. Ramaekers, G. Kauert, E. Theunissen, S. Toennes, M. Moeller (2009)
Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis usersJournal of Psychopharmacology, 23
C. Hunt, R. Jones (1980)
Tolerance and disposition of tetrahydrocannabinol in man.The Journal of pharmacology and experimental therapeutics, 215 1
C. Wanke, M. Silva, T. Knox, J. Forrester, D. Speigelman, S. Gorbach (2000)
Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 31 3
Diane Prentiss, R. Power, Gladys Balmas, Gloria Tzuang, D. Israelski (2004)
Patterns of Marijuana Use Among Patients With HIV/AIDS Followed in a Public Health Care SettingJAIDS Journal of Acquired Immune Deficiency Syndromes, 35
D. Abrams, J. Hilton, R. Leiser, S. Shade, T. Elbeik, F. Aweeka, N. Benowitz, B. Bredt, B. Kosel, J. Aberg, S. Deeks, T. Mitchell, K. Mulligan, P. Bacchetti, J. McCune, M. Schambelan (2003)
Short-Term Effects of Cannabinoids in Patients with HIV-1 InfectionAnnals of Internal Medicine, 139
D. Sheskin (1997)
Handbook of Parametric and Nonparametric Statistical ProceduresTechnometrics, 46
M. Haney, Erik Gunderson, J. Rabkin, C. Hart, S. Vosburg, S. Comer, R. Foltin (2007)
Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and SleepJAIDS Journal of Acquired Immune Deficiency Syndromes, 45
C. Johanson, E. Uhlenhuth (2004)
Drug preference and mood in humans: DiazepamPsychopharmacology, 71
E. Davidson, J. Finch, S. Schenk (1993)
Variability in subjective responses to cocaine: initial experiences of college students.Addictive behaviors, 18 4
D. Sheskin (2000)
Handbook of parametric and nonparametric statistical procedures, 2nd ed.
(1999)
Food “cravings
(2008)
Blunted psychotomimetic and amnestic effects of delta9tetracannabinol in frequent users of cannabis
L. Grinspoon, J. Bakalar (1993)
Marihuana: The Forbidden Medicine
C. Bell (1994)
DSM-IV: Diagnostic and Statistical Manual of Mental DisordersJAMA, 272
(1973)
Reliability, validity, and clinical
B. Martin (2002)
Medical marijuana—moving beyond the smokeThe Lancet, 360
A. Parrott, N. Garnham, K. Wesnes, C. Pincock (1996)
Cigarette Smoking and Abstinence: Comparative Effects Upon Cognitive Task Performance and Mood State over 24 HoursHuman Psychopharmacology: Clinical and Experimental, 11
(2008)
Nausea and vomiting in HIV
(1997)
Long-term efficacy and safety of dronabinol
M. Haney, A. Bisaga, R. Foltin (2003)
Interaction between naltrexone and oral THC in heavy marijuana smokersPsychopharmacology, 166
W. Hall, L. Degenhardt (2003)
Medical Marijuana InitiativesCNS Drugs, 17
D. Dansak (1997)
Medical use of recreational drugs by AIDS patients.Journal of addictive diseases, 16 3
Donald Abrams (1998)
Medical marijuana: tribulations and trials.Journal of psychoactive drugs, 30 2
M. Haney, J. Rabkin, Erik Gunderson, R. Foltin (2005)
Dronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and moodPsychopharmacology, 181
(1999)
THC administration to humans. Psychopharmacology. 1999a; 141:385–394
D. Abrams (2000)
Potential Interventions for HIV/AIDS Wasting: An OverviewJAIDS Journal of Acquired Immune Deficiency Syndromes, 25
E. Davidson, S. Schenk (1994)
Variability in subjective responses to marijuana: initial experiences of college students.Addictive behaviors, 19 5
M. Haney, C. Hart, S. Vosburg, Jennifer Nasser, Andrew Bennett, C. Zubaran, R. Foltin (2004)
Marijuana Withdrawal in Humans: Effects of Oral THC or DivalproexNeuropsychopharmacology, 29
D. D’Souza, M. Ranganathan, Gabriel Braley, R. Gueorguieva, Z. Zimolo, T. Cooper, E. Perry, J. Krystal (2008)
Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of CannabisNeuropsychopharmacology, 33
S. Watson, J. Benson, J. Joy (1999)
Marijuana and Medicine: Assessing the Science Base
S. Evans, R. Foltin, M. Fischman (1999)
Food “Cravings” and the Acute Effects of Alprazolam on Food Intake in Women with Premenstrual Dysphoric DisorderAppetite, 32
Jeffrey Beal, Richard Olson, Lewis Lefkowitz, Linda Laubenstein, Paul Bellman, Bienvenido G. Yangco, Javier Morales, Robert Murphy, William Powderly, Terry Plasse, Kristen Mosdell, Kirk Shepard (1997)
Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia.Journal of pain and symptom management, 14 1
(2004)
Marijuana withdrawal in humans: effects
Jeffrey Beal, R. Olson, L. Laubenstein, J. Morales, P. Bellman, B. Yangco, Lewis Lefkowitz, T. Plasse, K. Shepard (1995)
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.Journal of pain and symptom management, 10 2
C. Hart, M. Haney, A. Ward, M. Fischman, R. Foltin (2002)
Effects of oral THC maintenance on smoked marijuana self-administration.Drug and alcohol dependence, 67 3
D. Taylor, R. Poulton, T. Moffitt, Padmaja Ramankutty, M. Sears (2000)
The respiratory effects of cannabis dependence in young adults.Addiction, 95 11
C. Ashton (2001)
Pharmacology and effects of cannabis: A brief reviewBritish Journal of Psychiatry, 178
M. Haney, A. Ward, S. Comer, R. Foltin, M. Fischman (1999)
Abstinence symptoms following smoked marijuana in humansPsychopharmacology, 141
D. Taylor, D. Fergusson, Barry Milne, L. Horwood, T. Moffitt, Malcolm Sears, R. Poulton (2002)
A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults.Addiction, 97 8
S. Chubineh, J. Mcgowan (2008)
Nausea and vomiting in HIV: a symptom reviewInternational Journal of STD & AIDS, 19
R. Mehra, B. Moore, K. Crothers, Jeanette Tetrault, D. Fiellin (2006)
The association between marijuana smoking and lung cancer: a systematic review.Archives of internal medicine, 166 13
C. Hart, A. Ward, M. Haney, S. Comer, R. Foltin, M. Fischman (2002)
Comparison of smoked marijuana and oral Δ9-tetrahydrocannabinol in humansPsychopharmacology, 164
A. Hazekamp, R. Ruhaak, L. Zuurman, J. Gerven, R. Verpoorte (2006)
Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol.Journal of pharmaceutical sciences, 95 6
Mallory Johnson, E. Charlebois, S. Morin, S. Catz, Risë Goldstein, R. Remien, M. Rotheram-Borus, J. Mickalian, L. Kittel, Farishta Samimy-Muzaffar, M. Lightfoot, C. Gore-felton, Margaret Chesney (2005)
Perceived adverse effects of antiretroviral therapy.Journal of pain and symptom management, 29 2
M. Haney, C. Hart, S. Vosburg, S. Comer, S. Reed, R. Foltin (2008)
Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapsePsychopharmacology, 197
(2008)
Blunted psychotomimetic
L. Hollister (2000)
An approach to the medical marijuana controversy.Drug and alcohol dependence, 58 1-2
In HIV-positive marijuana smokers, high dronabinol doses safely and effectively increased caloric intake. However, repeated high-dose dronabinol appeared to result in selective tolerance to these effects. These findings indicate that HIV-positive individuals who smoke marijuana may require higher dronabinol doses than are recommended by the FDA. Future research to establish optimal dosing regimens, and reduce the development of tolerance, is required.
Psychopharmacology – Springer Journals
Published: Dec 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.